Overview
Juvenile nasopharyngeal angiofibroma (JNA) is a benign but locally aggressive vascular tumor that primarily affects adolescent males, arising in the nasopharynx and often extending into paranasal sinuses or the skull base. 1Diagnosis
Clinical Presentation: Nasal obstruction, epistaxis, and hearing loss.
Imaging: MRI and CT scans essential for tumor extent and involvement.
Angiography: Preoperative assessment to evaluate vascularity and guide embolization. 1
Grading: Fisch staging system categorizes tumors based on extent of growth; modifications proposed for better outcomes assessment. 1Management
First-Line Treatment: Surgical resection, often requiring endoscopic-assisted approaches for better visualization and control.
Adjunctive Therapy: Transarterial embolization with particulate agents prior to surgery to reduce intraoperative blood loss. 1
Surgical Techniques: Endoscopic-assisted midfacial degloving recommended for Fisch stage III JNA to improve surgical outcomes. 1Special Populations
Pediatrics: Endoscopic techniques are increasingly favored in pediatric patients due to reduced morbidity. 1Key Recommendations
Utilize preoperative transarterial embolization with particulate agents to minimize intraoperative blood loss in Fisch stage III JNA patients. (Evidence: Moderate) 1
Consider endoscopic-assisted midfacial degloving for surgical resection of stage III JNA to enhance visualization and control, potentially improving outcomes. (Evidence: Moderate) 1
Implement a modified Fisch staging system for better preoperative evaluation and comparative analysis of treatment outcomes for stage III JNA. (Evidence: Expert opinion) 1References
1 Shah SR, Keshri A, Patadia S, Sahu RN, Srivastava AK, Behari S. Stage III nasopharyngeal angiofibroma: Improving results with endoscopic-assisted midfacial degloving and modification to the Fisch staging system. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 2015. link